The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization ...

CareDx Inc. has entered a strategic collaboration with 10x Genomics to establish ImmuneScape, a multiomics research ...

The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).

Advances in multi-omics have led to large scale studies that can provide a better prediction method for adequate therapy choices in patients with chronic lymphocytic leukemia (CLL). Large scale ...

Genomics and transcriptomics are central pillars of modern life sciences, providing a comprehensive framework to unravel the complexities of biological systems. Genomics focuses on the structure, ...

Complete Genomics will share details of various multi-omics and spatial transcriptomics applications based on its sequencing technology at the 2024 American Society of Human Genetics (ASHG) Meeting.

LAUSANNE, Switzerland--(BUSINESS WIRE)--Alithea Genomics, a leader in the field of large-scale RNA sequencing and transcriptomics, announced today the launch of MERCURIUS™ Full-Length DRUG-seq library ...

Not so long ago, the omics field was a highly siloed collection of specialized applications and technologies. Now, multiomics is going mainstream. But as researchers revel in single cell resolution, ...

Spatial transcriptomics - New agreement to be the exclusive distributor of STOmics products in the U.S. STOmics, which specializes in solutions for spatial multi-omics through an advanced ...

The OmicsSuite native innovation framework architecture and the integration of the Posit Shiny framework. The yellow arrows show logical steps, while the blue arrows indicate datasets inputs and ...

With the advent of new omics technologies in recent years, there has been a deluge of complex, high-dimensional data on Alzheimer's disease (AD). A topical collection of articles on omics approaches ...

Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...